Key Patient Factors in Determining an Optimal Biologic Therapy

Opinion
Video

An expert rheumatologist highlights the billing process for patients receiving biologic therapies, as well as a study that highlights patient reported outcomes in patients with inflammatory arthritis utilizing intravenous biologics.

Video content above is prompted by the following questions:

  • What is the difference in the billing process with IV and subQ therapies? What are the pros and cons of each?
  • Patient reported outcomes have been assessed for patients with inflammatory arthritis utilizing IV biologics. What did this study demonstrate and does it impact your clinical practice?

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Recent Videos
2 experts are featured in this series.
1 expert is featured in this series.
1 expert in this video
1 expert in this video
1 expert in this video
2 experts are featured in this series.
1 expert is featured in this series.
1 expert in this video
1 expert in this video
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.